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The antiviral compounds quartromicins represent
unique members of a family of spirotetronate natural
products. In this study, a biosynthetic gene cluster of
quartromicins was identified by degenerate primer
PCR amplification of specific genes involved in the
biosynthesis of the tetronate moiety. The biochem-
ical results confirmed that 1,3-bisphosphoglycerate
was incorporated into the tetronate ring, and the
intermediates of this ring were also reconstructed
in vitro. The data also suggested a module skipping
strategy for the production of two alternative poly-
ketide chains by the same polyketide synthase
assembly line. These findings set the stage for further
investigations of the stereodivergent intermolecular
cyclization mechanism, and highlight how nature
has constructed this type of C2 symmetric molecule
through intermolecular dimerization.
INTRODUCTION
Spirotetronate antibiotics are a growing family of natural prod-
ucts with a wide range of biological activities, as exemplified
by the antitumor agents tetrocarcin A (TCA; Tomita et al.,
1980) and kijanimicin (Waitz et al., 1981; Figure 1A), the antiviral
drug MM46115 (Ashton et al., 1990), the antibacterial
compounds chlorothricin (CHL; Kawashima et al., 1992) and
abyssomicin (ABY; Riedlinger et al., 2004; Figure 1A), and the
cholecystokinin B inhibitor tetronothiodin (Ohtsuka et al.,
1993). Quartromicins (QMNs; Figure 1B) are an unusual group
of spirotetronate natural products isolated from Amycolatopsis
orientalis Q427-8 that include six components: A1, A2, A3, D1,
D2, and D3 (Kusumi et al., 1991; Tsunakawa et al., 1992; Roush
and Barda, 2002). This group of compounds exhibits significant
antiviral activity against herpes simplex virus type 1, influenza
virus type A, and HIV (Tsunakawa et al., 1992; Tanabe-Tochikura
et al., 1992). Until 2002, the stereochemical configuration of
QMNs was only partly assigned by nuclear magnetic resonance
(NMR) analysis (Roush and Barda, 2002). In addition to the
remarkable spirotetronate units of this family of products,
QMNs possess several unique structural elements. First, theChemistry & Biology 19, 1313–1novel 32-member carbocyclic architecture consists of four
spirotetronic acid units that are connected by enone linkers in
a head-to-tail fashion, resulting in one of only a few macrocyclic
compounds whose carbon framework is composed of only C-C
linkages. Second, QMN A3 and D3 are C2 symmetric, resulting
from a junction between diastereoisomeric (endo- and exo-)
spirotetronate subunits. Third, the four contiguous quaternary
carbon stereocenters in the spirotetronate fragments (C4/C12
and C40/C120 in the exo fragments, and C22/C30 and C220/
C300 in the endo fragments) also distinguish them from other
spirotetronate antibiotics.
The structural novelty of this family combined with its impres-
sive biological activity has spurred considerable interest in the
biosynthesis of spirotetronate antibiotics. The gene clusters of
CHL (Jia et al., 2006), kijanimicin (Zhang et al., 2007), TCA
(Fang et al., 2008), and ABY (Gottardi et al., 2011) have all
been cloned and characterized. Based on a series of in vivo
and in vitro experiments, including biosynthetic studies of the
tetronate antibiotics tetronomycin (TMN; Figure 1A; Demydchuk
et al., 2008; Sun et al., 2008) and RK-682 (Sun et al., 2010),
a reasonable biosynthetic route for tetronate moiety has been
deduced. In these compounds, a polyketide unit and a glyc-
erol-derived, three-carbon unit (glyceryl-S-ACP) are usually
used to form the tetronate moiety. It has shown that the polyke-
tide unit is synthesized by a module type I polyketide synthase
(PKS), and glyceryl-S-ACP is synthesized by an FkbH-like glyc-
eryl-S-ACP synthase (ChlD1, KijC, Tmn16, TcaD1, and RkE),
which catalyzes D-1,3-bisphosphosphoglycerate (1,3-BPG) to
dephosphorize and transfer to a discrete acyl carrier protein
(ACP; ChlD2, KijD, Tmn7a, TcaD2, and RkF). In RK-682 biosyn-
thesis, a FabH-like 3-oxoacyl-ACP synthase III (RkD) catalyzes
both C-C andC-O bond formation to generate a tetronatemoiety
from glyceryl-S-ACP and the ACP-bound nascent polyketide
chain (Sun et al., 2010). However, whether a similar process is
used to construct the tetronate moiety in other cases is unclear.
Given the fact that symmetric skeletons and spirotetronate
subunits with reverse chirality make QMN distinct from other
previously studied systems, unique mechanisms should be
included in its biosynthetic process. In this work, we identified
the QMN gene cluster by using the degenerate primers of the
tetronate locus. We then reconstructed the tetronate interme-
diate in vitro and biochemically characterized a PKS module
skipping strategy that is responsible for producing two alterna-
tive polyketide chains.323, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1313
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Figure 1. Structures of QMN and Related
Natural Products
(A) The tetronate moiety is boxed and the three-
carbon unit derived from 1,3-BPG is circled.
(B) The exo-spiro center is marked with a black dot
and theendo-spirocenter ismarkedwithagraydot.
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Cloning and Sequencing of the QMN Biosynthetic Gene
Cluster
FkbH-like glyceryl-S-ACP synthase is necessary for biosynthesis
of the tetronate moiety of spirotetronate antibiotics. Because
a homologous enzyme was predicted to mediate the biosyn-
thesis ofQMNs,wedesigneddegenerate primers (TableS2avail-
able online) according to the ChlD1 homolog gene encoding
FkbH-like glyceryl-S-ACP synthase. Using these primers and
the genomic DNA from A. orientalis Q427-8 as a template, we
acquired a DNA fragment (P1, Figure 2A). We then screened
the A. orientalis Q427-8 genomic library using the P1 product
as a probe, which resulted in several overlapping fosmids span-
ning a 50 kb DNA region. To ensure full coverage of the entire
QMN gene cluster, we conducted chromosome walking from
the left end of fosmid pTG4001 by using the PCR product P2 as
a probe (Figure 2A). Further chromosome walking using a similar1314 Chemistry & Biology 19, 1313–1323, October 26, 2012 ª2012 Elsevier Ltd All rights resstrategy led to a 90 kb contiguous DNA
region on the chromosome, which was
mapped in two overlapping fosmids
(pTG4001 and pTG4002; Figure 2A).
DNA sequencing of the two fosmids
yielded an 88,324 base pair (bp) con-
tiguous DNA sequence with 71.4%
guanine-cytosine content, which is char-
acteristic of Amycolatopsis DNA (Zhao
et al., 2010). A bioinformatic analysis of
the region revealed 47 open reading
frames (ORFs), 28 of which (from qmnB
to qmnRg5; Figure 2A; Table 1) were
proposed to constitute the QMN gene
cluster according to functional assignment
of their deduced products. Genes beyond
this region encode hypothetical proteins
and lack significant similarity to those
involved in secondary metabolite biosyn-
thesis. The difficult genetic manipulations
in the recalcitrant endogenous producer
A. orientalis Q427-8 and unstable pro-
duction of QMNs hindered further investi-
gation of the gene cluster in vivo, and
heterologous expression of the entire
cluster in a surrogate host was unsuc-
cessful. Therefore, the actual borders of
the cluster were not determined.
Bioinformatic Analysis of the QMN
Cluster
Three PKS genes, qmnA1, qmnA2, and
qmnA3, encode six PKS modulescontaining a total of six acyltransferases (ATs), six b-ketoacyl
synthases (KSs), six ACPs, four ketoreductases (KRs), and four
dehydratases (DHs; Figure 2B). The first loading module (M-L)
contains a mutant KSQ domain that functions as a malonyl-thio-
ester decarboxylase (Bisang et al., 1999), and the other KS
domains are all functional due to the presence of the conserved
catalytic triad of C-H-H (Figure S4A). Each AT domain bears
a highly conserved active site of GHSxG (Figure S4A). A
substrate-binding motif specific for malonyl-CoA (MCoA) was
found in M-L, M-3, and M-5, and methylmalonyl-CoA (MMCoA)
specificity-conferring residues were identified in M-1, M-2, and
M-4 (Reeves et al., 2001). All ACPs contain a signature motif
around the invariable 40-phosphopantetheine attachment site
Ser residue (Figure S4A), and DHs contain a conserved active
site with an H-D catalytic dyad (Akey et al., 2010). The KRs
contain a signature NADPH-binding site as well as an active
site consisting of S-Y and LDD motifs of B-type KRs to produce
a hydroxyl group of R stereochemistry (Keatinge-Clay, 2007).erved
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Figure 2. Biosynthetic Gene Cluster and Pathway of QMN
(A) Organization of the gene cluster.
(B) Proposed model for the biosynthesis of QMN.
See also Tables S1and S2 and Figure S4.
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Table 1. Deduced Functions of ORFs in the QMN Biosynthetic Gene Cluster
Gene
Amino
Acid Protein Homolog (Accession Numbera); Origin
Similarity/
Identity (%) Proposed Function
Orf-3b 247 short-chain dehydrogenase (EHR61900.1); Saccharomonospora
cyanea NA-134
83/77 unknown
Orf-2b 283 a/b hydrolase protein (ACZ87498); Streptosporangium roseum
DSM 43021
75/64 unknown
Orf-1b 308 conserved hypothetical protein (EFL10610); Streptomyces sp. AA4 82/73 unknown
qmnB 471 AccD6 (AAS04317);Mycobacterium avium subsp. paratuberculosis K-10 77/64 propionyl-CoA carboxylase
qmnC 251 thioesterase (EFN18142); S. violaceusniger Tu 4113 80/65 TE II
qmnD4 322 ChlD4 (AAZ77706); S. antibioticus 63/50 2-oxoacid dehydrogenase/AT
qmnA1 5924 KijS1 (ACB46488); Actinomadura kijaniata 63/52 PKS (KSQ-AT-ACP-KS -AT-DH-
KR-ACP-KS-AT-DH-KR-ACP-
KS-AT-DH-KR-ACP)
qmnA2 1771 ORF 20 (ABM47021); A. orientalis 66/54 PKS (KS-AT-DH-KR-ACP)
qmnA3 1292 ChlA6 (AAZ77699); S. antibioticus 71/60 PKS (KS-AT-ACP)
qmnE 412 b-lactamase (EFL23320); S. himastatinicus ATCC 53653 66/56 unkown
qmnF 396 cysteine desulfurase (EFL10316); S. sp. AA4 67/54 unknown
qmnRg1 255 ChlF2 (AAZ77687); S. antibioticus 71/59 regulator
qmnG 533 Ken10 (CAQ52613); S. violaceoruber 74/61 PQQ-dependent dehydrogenase
qmnH 376 – – unknown
qmnI 348 hypothetical protein SrosN15_20443 (ZP_04695314);
S. roseosporus NRRL 15998
54/36 unknown
qmnJ 161 conserved hypothetical protein (ADH70169); Nocardiopsis
dassonvillei subsp. dassonvillei DSM 4311
57/35 unknown
qmnRs1 392 ABC transporter-like protein (EDY52293); S. clavuligerus ATCC 27064 70/54 transporter
qmnRs2 227 macrolide efflux ABC transporter (EFF80341); Actinomyces
odontolyticus F0309
78/61 transporter
qmnK 352 peptidoglycan-binding domain 1 protein (EFN14959);
S. violaceusniger Tu 4113
54/37 unknown
qmnL 152 hypothetical protein Ndas_4785 (ADH70169); Nocardiopsis
dassonvillei subsp. dassonvillei DSM 43111
51/33 unknown
qmnM 219 hypothetical protein SVEN_6245 (CCA59531); S. venezuelae
ATCC 10712
51/41 unknown
qmnN 130 hypothetical protein SVEN_6245 (CCA59531); S. venezuelae
ATCC 10712
53/39 unknown
qmnRg2 449 putative two-component sensor kinase (CAJ62689);
Frankia alni ACN14a
69/60 regulator
qmnRg3 222 two-component system response regulator (CAJ62690);
Frankia alni ACN14a
88/80 regulator
qmnD5 343 ChlM (AAZ77702); S. antibioticus 75/62 3-oxoacyl-ACP synthase III (KS)
qmnD1 613 ChlD1 (AAZ77703); S. antibioticus 73/62 glyceryltransferase/phosphatase
qmnD2 71 Tmn7a (BAF73715); S. sp. NRRL 11266 77/65 ACP
qmnD3 281 Tmn7 (BAE93721); S. sp. NRRL 11266 76/65 2-oxoacid dehydrogenase/AT
qmnO 403 FadC (AAW81703); Pseudonocardia autotrophica 72/56 cytochrome P450
qmnRg4 935 LuxR family transcriptional regulator (CAM02144);
Saccharopolyspora erythraea NRRL 2338
66/52 regulator
qmnRg5 821 SARP family transcriptional regulator (ACU37101);
Actinosynnema mirum DSM 43827
55/44 regulator
orf(+1)b 734 probable exodeoxyribonuclease V (AAG23283);
Saccharopolyspora spinosa
91/84 exodeoxyribonuclease
orf(+2)b 240 precorrin 6A synthase (ABD12019); Frankia sp. CcI3 75/62 precorrin 6A synthase
orf(+3)b 435 NADH dehydrogenase (EFL07579.1); Streptomyces sp. AA4 81/74 NADH dehydrogenase
aAccession numbers deposited in the GenBank database.
borfs beyond the QMN gene cluster.
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polyketide chain 1, which was hypothesized to be an interme-
diate of path A for the biosynthesis of QMN (Figure 2B). In
addition, a propionyl-CoA carboxylase (QmnB) and type II
thioesterase (QmnC) involved in this pathway were considered
to be responsible for providing the MMCoA precursor and edit-
ing aberrant polyketide intermediates on a PKS assembly line,
respectively.
As expected, the presence of homologs of the five conserved
genes (qmnD1–D5) in the QMN cluster further supports the
common unifying paradigm for tetronate biosynthesis, which is
also consistent with the ABY cluster that was recently genetically
characterized (Gottardi et al., 2011). These gene products show
extremely high homology to the enzymes involved in CHL and
TMN biosynthesis (50%–65% identity and 60%–75% similarity).
Based on studies showing that RkD, an FabH-like b-ketoacyl-
ACP synthase III (KS III), is required for RK-682 formation from
ACP-bound substrates (Sun et al., 2010), we concluded that
QmnD1, similarly to ChlD1, KijC, Tmn16, TcaD1, RkE, and
AbyA2, provides both glyceryltransferase and phosphatase
(GAT) activities to load a three-carbon glyceroyl group from
1,3-BPG onto QmnD2 (a discrete ACP homologous to ChlD2,
KijD, Tmn7a, TcaD2, RkF, and AbyA3), yielding glyceryl-S-
ACP. QmnD5 (homologous to ChlM, KijB, Tmn15, TcaD4, RkD,
and AbyA1) may catalyze C-C and C-O bond formation from
glyceryl-S-ACP and the ACP-S-tethered nascent polyketide
chain to generate tetronate intermediates 3 and 4 (Figure 2B).
Additional comparative analyses of QMN, TMN, ABY, and
RK-682 biosynthetic machinery revealed that QmnD3 and
QmnD4 (the 2-oxoacid dehydrogenase/AT homologs, similar
to ChlD3/ChlD4, KijE, Tmn7/Tmn17, TcaD3, and AbyA4/
AbyA5) may catalyze the dehydration of intermediates 3 and 4
to yield intermediates 5 and 6 (Figure 2B).
QmnO contains a typical heme-binding motif (FGHGAHxCLG)
and is homologous to the known cytochrome P450 oxidase
FadC (Chen et al., 2005). It is also a candidate enzyme for
hydroxylation at C-8, C-80, C-26, and C-260 of QMN (Figure 1B).
QmnG bears a conserved pyrrolo-quinolinequinone (PQQ)-
binding motif and shows high sequence homology to Ken10
(61% identity and 74% similarity), which is a putative
PQQ-dependent alcohol dehydrogenase from the kendomycin
biosynthetic pathway (Wenzel et al., 2008). Therefore, it may
be responsible for further oxidization of the hydroxyl group
into aldehyde at the C-8 and C-80 positions, both of which
have been proposed to tailor modification steps involved in
the production of QMNs from intermediate 9 (Figure 2B). In
addition, QmnE exhibits sequence homology to b-lactamase
(56% identity and 66% similarity), and QmnF shows similarity
to pyridoxal phosphate (PLP)-dependent cysteine desulfurase
(54% identity and 67% similarity). However, the exact roles of
these proteins in the QMN biosynthetic pathway remain to be
elucidated.
Five genes encode putative regulatory proteins, including
a ChlF2-like regulator (QmnRg1), a pair of two-component
regulators (QmnRg2-Rg3), a LuxR family regulator (QmnRg4),
and a SARP family activator (QmnRg5). Two genes within this
cluster, qmnRs1 and qmnRs2, encode ABC transporters as
resistant proteins to ensure efficient self-protection. In addition,
there are seven genes (qmnH, qmnI, qmnJ, qmnK, qmnL, qmnM,Chemistry & Biology 19, 1313–1and qmnN) encoding proteins that either show no obvious
homology to any proteins in the databases or resemble
proteins with unknown functions. Therefore, the roles of these
genes in QMN biosynthesis could not be predicted by sequence
analysis.
Biochemical Characterization of Long Polyketide Chain
Biosynthesis through Path A by a Colinearity Model
The QMN PKS contains six modules that are consistent with the
structure of long polyketide chain 1 following the colinearity
model (path A in Figure 2B). To explore the biosynthesis of 1
in vitro, the M-4 protein QmnA2, which contains five domains
with KS-AT-DH-KR-ACP organization, was separated, ex-
pressed, and purified as two proteins: QmnA20 (KS4-AT4-DH4-
KR4) and ACP4 from Escherichia coli BL21 (DE3). In addition,
ACP3-1 (the ACP domain of M-3 containing N-His6 tag),
QmnA3, and ACP5 (the ACP domain of M-5) were also ex-
pressed and purified for use in the biochemical assay (Figure S5).
Using 40-phosphopantetheinyltransferase (Sfp; Quadri et al.,
1998), intermediate 11-1 was synthesized with polyketide-CoA
10 and apo-ACP3 as substrates (Figure 3A). When the assay
containing 11-1 was combined with QmnA20, holo-ACP4, and
MM-CoA, an elongated product 12 was observed by high-
performance liquid chromatography (HPLC) and liquid chroma-
tography-mass spectroscopy (LC-MS) analysis (Figure 3B;
Figure S7; Table S3). In addition, the further modification product
13 also appeared by following NADPH-dependent ketoreduction
and dehydration catalyzed by KR and DH domains (Figure 3B;
Figure S7; Table S3). Next, when 13 (which was also produced
by Sfp using polyketide-CoA 14 and apo-ACP4) and MCoA
were incubated with QmnA3 and holo-ACP5 together, the
polyketide elongation product 1 was produced, which was
supported by the generation of derivative 15, as detected by
HPLC analysis and further confirmed by LC-MS (Figure 3C;
Figure S8; Table S3). The concomitant decrease of substrates
holo-ACP5 and 13 and increase in the products holo-ACP4
and 15 (Figure 3C) is consistent with the expected results of
polyketide chain elongation.
Biochemical Characterization of Short Polyketide Chain
Biosynthesis through Path B by Module Skipping
Because no additional PKS modules were identified in the
presumed cluster, we hypothesized that the short polyketide
chain was also constructed by the same PKS assembly line.
However, in order to fit the short polyketide chain 2, the M-4
protein QuaA2 should be programmably skipped during the
PKS assembly (path B in Figure 2B). To verify this module
skipping mechanism, another protein, ACP3-2, was expressed
and purified (also the ACP domain of M-3 containing N-His6
and C-His6; the retention time in HPLC analysis was slightly
different from ACP3-1). Similarly, 11-2 was synthesized using
polyketide-CoA 10 and apo-ACP3-2 as substrates catalyzed
by Sfp (Figure 3A). When 11-2 and M-CoA were incubated with
QmnA3 and holo-ACP5 together, the polyketide elongation
product 2 was produced and followed by thioester exchanging
to yield 16, which was detected by HPLC analysis and further
confirmed by LC-MS (Figure 3D; Figure S9; Table S3). In addi-
tion, the change in the ratios between substrates and products
also supports the expected enzymatic reactions.323, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1317
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Biosynthesis In Vitro
To date, TcaD1 in the TCA pathway (Fang et al., 2008), Tmn16 in
the TMN biosynthesis pathway (Sun et al., 2008), and RkE in the
RK-682 biosynthesis pathway (Sun et al., 2010) have been
biochemically confirmed to have GAT activities. However, only
RkD in the RK-682 biosynthetic pathway was proposed to
catalyze C-C and C-O bond formation based on in vitro data
(Sun et al., 2010). Therefore, we first cloned qmnD1, qmnD2,
qmnD5, and qmnA3-ACP5 genes, heterologously expressed
them in E. coli BL21 (DE3), and purified the respective proteins
to homogeneity (Figure S5). HPLC and electrospray ionization
(ESI)-MS analysis confirmed that QmnD2 (ACP) is in apo-form
(Figure 4BI; Figure S6; Table S3). When it was incubated with
CoA and the Sfp, apo-ACP was converted into the functional
holo form (Figure 4BII; Figure S10). To verify glyceryl transfer
reactions catalyzed by QmnD1, the purified protein was incu-
bated with ATP, Mg2+, D-3-phosphoglycerate (3-PG), and
3-PG kinase for generation of 1,3-BPG in situ, and then the
holo-QmnD2 was added to directly test glyceryl loading (Fig-
ure 4A). Reaction mixtures were subjected to HPLC analysis
(Figure 4BIII) and the reaction products were also subjected to
quadrupole time-of-flight (Q-TOF)-MS analysis. As expected,
the addition of 88.0 Da to holo-QmnD2 to generate 17 was in
exact agreement with themass increase for glycerate (Figure 4C;
Figure S4; Table S3). We then synthesized 16 using the polyke-
tide-CoA 18 and apo-ACP5 as substrates catalyzed by Sfp (Fig-
ure 4BIV; Figure S10). When 16 and 17 were incubated with
QmnD5 together, HPLC analysis confirmed that the decrease
of substrates was obvious (Figure 4BV) and the tetronate
product 4 was detected by analysis of the reaction products
using LC-MS (Figure 4D). This was further confirmed by
MS/MS (Figure 4E). Together, these in vitro results strongly
support the notion that 1,3-BPG can be effectively activated
by QmnD1 and subsequently dephosphorylated. This step is
followed by the transfer onto holo-QmnD2 to form glyceryl-S-
ACP intermediate 17, and subsequent coupling with the
QmnA3-ACP5-tethered nascent polyketide chain catalyzed by
QmnD5 to produce tetronate intermediate 4 (Figure 4A).
DISCUSSION
In most cases, modular PKSs synthesize polyketides through
successive Claisen condensations, and one module is respon-
sible for one round of chain extension. However, an increasing
number of exceptions are being characterized, revealing other
strategies beyond the colinearity model for an assembly line of
modular PKS (Moss et al., 2004). One well-described example
is pikromycin PKS, which generates 12- and 14-membered
ring macrolactones, most likely through a programmed module(B) HPLC and Q-TOF-MS analysis of the first step of 1 biosynthesis via path A
holo-ACP4, chain elongation yielding 13 (III, in the presence of NADPH) an
substrate.
(C) HPLC and Q-TOF-MS analysis of the second step of 1 biosynthesis via path A
and (III) chain elongation yielding 15 catalyzed by QmnA3 using 13 as substrate.
(D) HPLC and Q-TOF-MS analysis of 2 biosynthesis via path B: (I) holo-ACP5, (II)
elongation yielding 16 catalyzed by QmnA3 using 10-2 as substrate.
See also Table S3 and Figures S1, S2, S4–S9, and S11–S14.
Chemistry & Biology 19, 1313–1skipping mechanism (Xue and Sherman, 2000; Beck et al.,
2002, 2003; Aldrich et al., 2005). Another PKS module skipping
phenomenon was observed in an engineered PKS system in
which both triketides and tetraketides were identified, and an
ACP transfer step was required to facilitate transfer of the
substrate over long distances (Thomas et al., 2002). In addition,
for nonribosomal peptide synthetase systems, myxochromide S
in Stigmatella aurantiaca was biosynthesized using a module
skipping process induced by a natural point mutation (Wenzel
et al., 2006). In the QMN biosynthetic pathway, we hypothesized
and biochemically confirmed that the QmnA1-QmnA2-QmnA3
PKS not only catalyzed the synthesis of long polyketide chain
1 (path A in Figure 2B) but also produced short polyketide chain
2 (path B in Figure 2B). These findings suggested that the
C-terminal docking domain of QmnA1 could recognize not only
theN-terminal docking domain of QmnA2but also theN-terminal
docking domain of QmnA3, whereas the C-terminal docking
domain of QmnA2 could only interact with the N-terminal dock-
ing domain of QmnA3. According to structural information about
docking domains in PKS genes (Broadhurst et al., 2003; Buch-
holz et al., 2009), all of the docking domains bear conserved
residues and contain well-matched amino acids for possible
salt bridges (Figure S4B). Two distinct mechanisms can be
considered for QMN polyketide chains biosynthesis: In one
mechanism, the QmnA1-QmnA2-QmnA3 assembly line may be
arranged by a linear mode, and the short polyketide chain 2
may be produced through a complete-module skipping mecha-
nism, similarly to the biosynthesis of myxochromide S. In the
other mechanism, QmnA1-QmnA2-QmnA3 may also be clus-
tered, in which case both domain KS4 and domain KS5 interact
with domain ACP3. In addition to domain ACP3, domain KS5
also interacts with domain ACP4 simultaneously (Figure S4C).
The bioconstruction of symmetric molecules by oligomeriza-
tion of the basic units through an ester or amide bond is usually
mediated by the thioesterase domain, which catalyzes the cyclo-
ologomerization process (Kohli and Walsh, 2003; Watanabe
et al., 2006; Cheng, 2006). QMNs bear a 32-member carbocyclic
architecture consisting of four spirotetronic acid units connected
by enone linkers in a head-to-tail fashion, so the carbon
frameworks are composed of only C-C linkages. Two hypoth-
eses have been proposed for the biosynthesis of QMNs: (1)
stereodivergent Prins-type cyclizations for the formation of the
stereoisomeric spirocylic units (Roush and Barda, 2002), or (2)
stereodivergent intermolecular Diels-Alder reactions between
pairs of 3-trienoyl- and 3-tetraenoyl-5-methylenefuran-2,
4-diones to form the spirotetronate and the 32-member carbo-
cycle (Montgomery and Challis, 2008). However, to date, no
genetic or biochemical information has been obtained to
support these models. The biochemical investigation of
QMN biosynthesis reveled that QmnD5, which is a FabH-like: (I) production of 11-1 using 10 and apo-ACP3-1 catalyzed by Sfp; and (II)
d 12 (IV, in the absence of NADPH) catalyzed by QmnA2 using 11-1 as
: (I) holo-ACP5, (II) production of 13 using 14 and apo-ACP4 catalyzed by Sfp,
production of 11-2 using 10 and apo-ACP3-2 catalyzed by Sfp, and (III) chain
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Figure 4. In Vitro Biochemical Characteriza-
tion of Tetronate Biosynthesis
(A) Biochemical investigations to construct the
tetronate moiety.
(B) Protein detection by HPLC analysis of purified
apo-QmnD2 (I), holo-QmnD2 (II), incubated with
QmnD1 (III), apo-QmnA3-ACP5 modified by Sfp in
the presence of 18 (IV), and entire reaction cata-
lyzed by QmnD5 (V).
(C) Q-TOF-MS analysis of holo-QmnD2 (I) and the
generation of glyceryl-S-QmnD2 17 (II).
(D) Chemical detection of 4 in the reaction cata-
lyzed by QmnD5 (II) and control with denatured
QmnD5 (I) by LC-MS analysis.
(E) Further confirmation of tetronate 4 production
by MS/MS analysis.
See also Table S3 and Figures S3, S5, S6, S10,
S15, and S16.
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tide chain release and further tetronate intermediate 4 formation.
We also suggest that the long tetronate intermediate 3 is synthe-
sized by the only KS III, QmnD5, using the same pathway
(Figure 2B). Then, QmnD3 and QmnD4 (the two-component
2-oxoacid dehydrogenase/AT-like enzymes) may catalyze the
two tetronate intermediates to dehydrate and give rise to the
3-polyenoyl-5-methylenefuran-2,4-dione intermediates 5 and 6
(Figure 2B). Next, two steps of [4 + 2] cycloaddition, possibly
through exo and endo Diels-Alder reactions, should be involved1320 Chemistry & Biology 19, 1313–1323, October 26, 2012 ª2012 Elsevier Ltd All rights resin the construction of symmetricaglycone
7 or 8 into 9, which can be further
modified by hydroxylation (QmnO), oxidi-
zation (QmnG), and even glycosylation to
produce all members of the QMNs (Fig-
ure 2B). Therefore, the stereodivergent
intermolecular Diels-Alder reaction to
form the spirotetronate and the 32-
member carbocycle (Montgomery and
Challis, 2008) is preferred.
Although the enzyme-catalyzed [4 + 2]
cycloaddition has attracted substantial
attention from scientists for a long time
(Oikawa and Tokiwano, 2004; Kelly,
2008), almost all of the proposed Diels-
Alder cycloadditions are intramolecular
cyclizations, including the lovastatin non-
aketide synthase (Auclair et al., 2000), the
recently characterized elansolid biosyn-
thesis (Dehn et al., 2011), solanapyrone
synthase (Kasahara et al., 2010), and the
likely Diels-Alderase SpnF in the biosyn-
thesis of spinosyn A (Kim et al., 2011;
Townsend, 2011). The macrophomate
synthase (MPS) is the most extensively
studied of all the putative Diels-Alderases
and catalyzes a total of four steps,
including the intermolecular [4 + 2]
cycloaddition (Ose et al., 2003). How-
ever, mixed quantum and molecular-mechanics simulations of MPS support a stepwise Michael-
Aldol reaction mechanism rather than a Diels-Alder reaction
(Guimara˜es et al., 2005). MPS was also shown to be an
efficient aldolase with a series of aldehyde substrates (Serafimov
et al., 2008). Therefore, our characterization of the QMN
biosynthetic gene cluster in this study not only provides another
opportunity to explore possible Diels-Alderases but also sets
the stage for further investigations of the enzymatic process
and mechanism of stereodivergent intermolecular [4 + 2]
cycloaddition.erved
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QMNsbelong to thegroupof spirotetronate natural products
and have a unique symmetrical structure with four spirotetr-
onate units. In this study, we cloned the biosynthetic gene
cluster of QMNs by degenerate primer PCR amplification
of specificgenes involved in thebiosynthesis of the tetronate
moiety. Our biochemical characterization of the biosynthetic
pathway suggests that there is a module skipping strategy
in the process of chain extension for building the short
polyketide chain, and that the module PKS assembly line
can be used to synthesize two alternative polyketide chains,
both of which are essential for the biosynthesis of QMNs.
This is an example of bacteria adopting an economical
approach for the biosynthesis of natural products. In addi-
tion, our biochemical results confirmed that 1,3-BPG was
incorporated into the tetronate ring, and even showed that
the tetronate moiety of spirotetronate antibiotics could be
reconstructed in vitro as Rk-682. Successful construction
of the tetronate moiety provides an opportunity to explore
the enzymatic process andmechanism of a possible stereo-
divergent intermolecular [4 + 2] cycloaddition.
EXPERIMENTAL PROCEDURES
General
A QMNs producer, A. orientalis Q427-8 (ATCC 53884), was purchased from
the American Type Culture Collection and cultured as described previously
(Tsunakawa et al., 1992). E. coli DH5a competent cells were used for routine
subcloning and plasmid preparations, and E. coli BL21(DE3) was used as
the protein expression host. E. coli cells were grown in LBmediumwith appro-
priate antibiotics, when necessary. Other plasmids are summarized in Table
S1. All other common biochemicals and chemicals were obtained from stan-
dard commercial sources. PCR amplification was carried out using either
Taq DNA polymerase or PfuUltra DNA polymerase with genomic DNA or
fosmid as a template, and degenerate or specific primers listed in Table S2.
Primer synthesis was performed at the Invitrogen Shanghai Center. DNA
sequencing was performed at Shanghai GeneCore Biotechnology Inc. Analyt-
ical HPLC was carried out on an Agilent 1200 HPLC system with a PDA
detector. LC-MS analysis was carried out on an Agilent 1200 HPLC instrument
connected to LCQ Fleet ESI mass spectrometer (Thermo Fisher Scientific).
ESI-MS was performed with a Shimadzu LCMS-2010 EV mass spectrometer.
Genomic Library Construction, Screening, and Sequence Analysis
A genomic library of A. orientalis Q427-8 was constructed in the fosmid vector
pCC1FOS-1 (Epicenter Technologies) according to the manufacturer’s
protocol. The D1 gene probes (P1) for library screening were obtained
by PCR amplification with primers ChlD1-For-1 (or ChlD1-For-2) and ChlD1-
Rev (Table S2), and confirmed by sequencing. The genomic library (4.0 3
103 clones) was screened by colony hybridization, and the resultant positive
clones were further confirmed by PCR amplification and southern blotting.
To extend the cloned DNA region on the chromosome, the library was further
screened by colony hybridization with probe P2 (a 0.83-kb PCR fragment with
Q-walk-For and Q-walk-Rev as primers) from pTG4001 (Figure 2A; PCR
primers are summarized in Table S2). The ORFs were deduced from the
sequence by means of the FramePlot 4.0beta program (http://nocardia.nih.
go.jp/fp4) and BLAST methods. Amino acid sequence alignments were
obtained using the CLUSTALWmethod with Biology WorkBench 3.2 software
(http://workbench.sdsc.edu). The functional domains of the PKSs were identi-
fied by using a program available from http://www.nii.res.in/searchall.html.
Protein Expression and Purification
The DNA fragments encoding individual target proteins were amplified by
PCR, using the cosmid pTG4001 as the template. The primers for the amplifi-Chemistry & Biology 19, 1313–1cation are listed in Table S2. The identity of each PCR product was confirmed
by sequencing. Each fragment was doubly digested with the corresponding
restriction endonuclease and ligated with pET28a, pET37b, or pF7 to provide
the plasmids for protein expression. The fragments coding QmnD1, QmnA1-
ACP3-1, and QmnA3-ACP5 were digested by NdeI/HindIII and ligated with
pET28a. The fragment coding QmnD2 was digested by NdeI/HindIII and
ligated with pET37b. Both of the fragments coding QmnA1-ACP3-2 and
QmnA2-ACP4 were digested by NdeI/XhoI; however, the former was ligated
with pET28a and the latter was ligated with pET37b. The fragment coding
QmnD5 was digested by EcoRI/HindIII and ligated with pF7. The longer genes
coding QmnA2 and QmnA3 were divided into two fragments. The two
fragments for QmnA2 were digested by NdeI/NotI and NotI/HindIII, respec-
tively, and three-segment-ligated with pET28a. The fragments for QmnA3
were digested by NdeI/XhoI and XhoI/HindIII, and also three-segment-ligated
with pET28a.
For overproduction of proteins, cells harboring the desired plasmid were
grown in LB medium supplemented with 50 mg/ml of kanamycin. Cultures
(1 l) were grown to an OD600 of 0.5 at 37
C and then cooled to 16C for
30min, and protein expression was induced by the addition of 50 mM isopropyl
b-D-thiogalactopyranoside. Cultures were grown for an additional 24 hr.
Purification of the His-tagged fusion protein with Ni-NTA affinity resin was
performed according to the manufacturer’s manual (QIAGEN), and the resul-
tant proteins were dialyzed against 50 mM MOPS (pH 7.5), 50 mM NaCl,
and 10% glycerol, and stored at 80C.
Chemical Synthesis of Acyl-SCoA 10, 14, and 18
The reactions were monitored by thin-layer chromatography with silica
gel-coated plates. Flash-column chromatography was carried out using
300–400 mesh silica gel at increased pressure. 1H and 13C NMR spectra
were recorded on a Bruker Ultrashield 400 (400 MHz) spectrometer in CDCl3
with tetramethylsilane as an internal standard. Chemical shifts are referenced
to residual protonated solvent (dH = 7.26 and dC = 77.16 for CDCl3) and given
in parts per million (ppm). For 1H NMR spectra, the multiplicity of a signal is
designated by one of the following abbreviations: s, singlet; d, doublet;
t, triplet; q, quartet; m,multiplet. All coupling constants, J, are reported in Hertz
and given to the nearest 0.1 Hz. Mass spectra were recorded using ESI.
Acyl-SCoA thioesters were purified by HPLC on a LC-20A3 vp HPLC system
(Shimadzu) with a Venusil XBP-C18 column (AGT, 10.0 3 250 mm, 5 mm)
with the following gradients at room temperature: 0–5 min, constant 95%
A/5% B; 5–20 min, a linear gradient to 30% A/70% B; 20–22 min, a linear
gradient to 5%A/95%B; 22–24min, constant 5%A/95%B; 24–26min, a linear
gradient to 95% A/5% B, and 26–30 min, constant 80% A/20% B (buffer A,
10 mM NH4OAc in H2O; and buffer B, CH3CN). This was performed at a flow
rate of 3 ml/min with UV detection at 310 nm. The synthetic routes and details
are summarized in Figures S1–S3.
In Vitro Reconstruction of Tetronate Building-Block Biosynthesis
To prepare holo-QmnD2, an assay (50 ml) containing 50 mM MOPS (pH 7.5),
10 mM MgCl2, 1 mM TCEP, 5 mM Sfp, 0.25 mM CoA, and 50 mM apo-
QmnD2 was incubated for 1 hr at 30C . To prepare 1,3-BPG in situ, a reaction
(30 ml) containing 50 mM MOPS (pH 7.5), 1 mM TCEP, 5 mM ATP, 0.25 mM
3-PG, 2 U 3-PG kinase, and 5 mM QmnD1 was incubated for 30 min at
30C. A portion of the reaction (20 ml) mixture was then added to the reaction
(30 ml) containing holo-ACP as described above and incubated at 30C for
30 min. To prepare 16, an assay (50 ml) containing 50 mM MOPS (pH 7.5),
10 mM MgCl2, 1 mM TCEP, 5 mM Sfp, 0.25 mM CoA 18, and 50 mM
Qmn-ACP5 was incubated for 1 hr at 30C, and then the portion containing
glyceroyl-S-ACP5 (50 mM; as described above) and 10 mMQmnD5 was added
for 6 hr. The reaction mixture was acidified with 1N HCl to pH 3, extracted with
ethyl acetate, and evaporated. The residue was dissolved in MeOH and
analyzed by LC-MS.
Biochemical Characterization of Polyketide Chain Biosynthesis
To prepare holo-ACP4 (or holo-ACP5), an assay (100 ml) containing 50 mM
MOPS (pH 7.5), 10 mM MgCl2, 1 mM TCEP, 5 mM Sfp, 0.25 mM CoA, and
50 mM apo-ACP4 (or apo-ACP5) was incubated for 1 hr at 30C.
An assay (50 ml) containing 50 mM MOPS (pH 7.5), 10 mM MgCl2, 1 mM
TCEP, 5 mM Sfp, 0.25 mM 10 (or 14), and 50 mM apo-ACP3-2 (or apo-ACP4,323, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1321
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Quartromicin Biosynthesisapo-ACP3-1) was incubated to prepare 11-2 (or 13, 11-1) at 30C for 1 hr, and
then QmnA2 (or QmnA3; 5 mM) was added. After incubation at 30C for 1 hr,
MM-CoA (or M-CoA; 0.25 mM), NADPH (1 mM) and 50 ml holo- ACP4 (or
holo-ACP5; 50 mM) were added. One assay in the absence of NADPH was
the control reaction.
Protein assays were analyzed by HPLC with a GraceVydac protein and
peptide C18 column with the following gradients at room temperature:
0–3 min, constant 80% A/20% B; 3–30 min, a linear gradient to 60% A/40%
B; 30–50 min, a linear gradient to 40% A/60% B; 50–52 min, a linear gradient
to 5% A/95% B; 52–54 min, constant 5% A/95% B; 54–56 min, a linear
gradient to 80% A/20% B, and 26–30 min, constant 80% A/20% B (buffer A,
0.1% TFA in H2O; buffer B, 0.1% TFA in CH3CN). This was performed
at a flow rate of 1 ml/min with UV detection at 220 nm. MS analysis was carried
out with an Agilent 6530 Accurate-Mass Q-TOF LC/MS. Analysis of small
molecules was carried out with a Venusil XBP-C18 column with the following
gradients: 0–5 min, constant 95A/20% B; 5–25 min, a linear gradient to 5%
A/95% B; and 25–40 min, a linear gradient to 5% A/95% B (buffer A, 0.1%
HCOOH and 10 mM NH4OAc in H2O; and buffer B, 0.1% HCOOH in CH3CN).
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